Shaylee Yount in Immunotherapy - Cancer and Beyond 896 Collaborate2Cure:Tumor In a Dish: Novel Approach for Personalized Medicine, Shrikant Anant, PhDDecember 8, 2017
Shaylee Yount in Immunotherapy - Cancer and Beyond 1,106 Collaborate2Cure: (2) Immune Monitoring Toolkit for Canine Immunotherapy Trials, Hans Rindt, PhD Sandra Bechtel, DVM, DACVIMNovember 17, 2016 (part 2)
Shaylee Yount in Immunotherapy - Cancer and Beyond 956 Collaborate2Cure: Immune Monitoring Toolkit for Canine Immunotherapy Trials, Jeffrey N. BryanNovember 17, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 939 Collaborate2Cure: Immunotherapy of Osteosarcoma, Laura Simon Treml, VMD, PhDNovember 10, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 821 Collaborate2Cure:Engineering Regulatory T Cells for the Treatment of Graft-Versus-Host Disease, Tom Yankee, PharmD, PhDNovember 10, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 877 Collaborate2Cure: Kansas City One Health Day, Zika Virus, Stephen Higgs, PhDNovember 3, 2016 - Kansas City One Health Day
Shaylee Yount in Immunotherapy - Cancer and Beyond 8391 Collaborate2Cure: Howling at the Cancer Moonshot, Carolyn Henry DVM, MS, DACVIMNovember 3, 2016 - Kansas City One Health Day
Shaylee Yount in Immunotherapy - Cancer and Beyond 8291 Collaborate2Cure: Treating Cancer with Ex Vivo-Activated Cancer Neoantigen-Specific Effector T Cells, Tammie WahausNovember 3, 2016 - Kansas City One Health Day
Shaylee Yount in Immunotherapy - Cancer and Beyond 7741 Collaborate2Cure: Practical Considerations for Translation of CAR-T Cell Therapies to the Market, Sara Mary Hall October 27, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 8561 Collaborate2Cure: inCVAX: An in situ Autologous Cancer Vaccine, Joseph Raker, PhDOctober 27, 2016
